Does improvement in case ascertainment explain the increase in sporadic Creutzfeldt-Jakob disease since 1970 in the United Kingdom?

被引:9
作者
Cohen, CH
机构
[1] Univ Bern, Inst Anim Neurol, Bern, Switzerland
[2] Fed Vet Off, Monitoring Grp, Bern, Switzerland
关键词
Creutzfeldt-Jakob syndrome; incidence; mortality; time factors;
D O I
10.1093/aje/152.5.474
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The aim of this study was to quantify the improvements in case ascertainment which are considered to explain the rise in the incidence of sporadic Creutzfeldt-Jakob disease. The numbers of cases, falling into five 10-year age groups starting at the age of 30 and three calendar periods of report since 1970, were analyzed by Poisson regression, assuming a constant age distribution. The age-period and age-cohort models were applied and discussed. The age-period model showed that underreporting in 1970-1979 was greater among patients aged 70 years or older. The age-cohort model indicated that a cohort factor increased over the first half of the 20th century (e.g., the incidence in the generation born in 1940 was almost twice that in the generation born in 1920); this increase was probably an artifact due to the past underascertainment pattern. However, from a statistical viewpoint, both models lead to a good fit; the cohort factor may appear to be as relevant as the period factor in describing the trends in incidence. Thus, one can imagine an unlikely worst case scenario, assuming that an unknown cohort factor is involved, in that case, the age-cohort model gives more optimistic predictions than Neilson's model (BMJ 1996;312:1038-9). These results are consistent with both interpretations: The rise in incidence is governed by improvements in case ascertainment, and is greater among old people (the most accepted interpretation); this rise may depend on a cohort factor as well, which may correspond to the zoonotic hypothesis (a totally hypothetical interpretation). Interpreting the increase of sporadic Creutzfeldt-Jakob disease over generations in terms of exposure to putative environmental factors is still a matter of debate; ongoing epidemiologic surveys may provide more information. Presently, this increase can be explained as an artifact due to the past underreporting pattern, with 79% (95% confidence interval: 56, 90) of the cases among persons aged greater than or equal to 70 years being missed in 1970-1979.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 21 条
[1]  
AYLIN P, 1996, POPUL TRENDS, V85, P34
[2]   Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].
Bruce, ME ;
Will, RG ;
Ironside, JW ;
McConnell, I ;
Drummond, D ;
Suttie, A ;
McCardle, L ;
Chree, A ;
Hope, J ;
Birkett, C ;
Cousens, S ;
Fraser, H ;
Bostock, CJ .
NATURE, 1997, 389 (6650) :498-501
[3]   Diagnosis and incidence of prion (Creutzfeldt-Jakob) disease: A retrospective archival survey with implications for future research [J].
Bruton, CJ ;
Bruton, RK ;
Gentleman, SM ;
Roberts, GW .
NEURODEGENERATION, 1995, 4 (04) :357-368
[4]   MODELS FOR TEMPORAL VARIATION IN CANCER RATES .1. AGE PERIOD AND AGE COHORT MODELS [J].
CLAYTON, D ;
SCHIFFLERS, E .
STATISTICS IN MEDICINE, 1987, 6 (04) :449-467
[5]   MODELS FOR TEMPORAL VARIATION IN CANCER RATES .2. AGE PERIOD COHORT MODELS [J].
CLAYTON, D ;
SCHIFFLERS, E .
STATISTICS IN MEDICINE, 1987, 6 (04) :469-481
[6]   When did bovine spongiform encephalopathy (BSE) start? Implications on the prediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic [J].
Cohen, CH ;
Valleron, AJ .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1999, 28 (03) :526-531
[7]   Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 [J].
Cousens, SN ;
Zeidler, M ;
Esmonde, TF ;
DeSilva, R ;
Wilesmith, JW ;
Smith, PG ;
Will, RG .
BRITISH MEDICAL JOURNAL, 1997, 315 (7105) :389-395
[8]   INTERNATIONAL VARIATIONS AND TEMPORAL TRENDS IN MORTALITY FROM MULTIPLE-MYELOMA [J].
CUZICK, J ;
VELEZ, R ;
DOLL, R .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (01) :13-19
[9]  
DAVANIPOUR Z, 1986, NEUROEPIDEMIOLOGY, V5, P196
[10]  
GORE S, 1997, BRIT MED J, V315, P397